TriangleNCT00104104 · OUTCOME
The Number of Participants With Disease Progression
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- NUMBER
- Unit
- Participants
- Interval / dispersion
- Not reported
- Time frame
- 24 Months
Analysis population: Safety Population; enrolled patients who received at least one dose of study medication.
Groups in this outcome
15 - Minute Infusion
Participants received 4 mg zoledronic acid intravenously, in 250 mL of fluid, every 3-4 weeks for up to 24 months, over a 15-minute infusion time, but increasing to a 30-minute infusion time if they experienced a clinically relevant rise in serum creatinine that resolved in less than 12 weeks.
30 - Minute Infusion
Participants received 4 mg zoledronic acid intravenously, in 250 mL of fluid, every 3-4 weeks for up to 24 months, over a 30-minute infusion time, but increasing to a 45-minute infusion time if they experienced a clinically relevant rise in serum creatinine that resolved in less than 12-weeks.
| Group | Source count |
|---|---|
| 15 - Minute Infusion | 85 |
| 30 - Minute Infusion | 84 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| 15 - Minute Infusion | 28 | Not reported | Not reported | Not reported | Not reported |
| 30 - Minute Infusion | 20 | Not reported | Not reported | Not reported | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- value
- 28
- group Id
- OG001
- value
- 20
- denoms
- counts
- group Id
- OG000
- value
- 85
- group Id
- OG001
- value
- 84
- units
- Participants
- groups
- description
- Participants received 4 mg zoledronic acid intravenously, in 250 mL of fluid, every 3-4 weeks for up to 24 months, over a 15-minute infusion time, but increasing to a 30-minute infusion time if they experienced a clinically relevant rise in serum creatinine that resolved in less than 12 weeks.
- id
- OG000
- title
- 15 - Minute Infusion
- description
- Participants received 4 mg zoledronic acid intravenously, in 250 mL of fluid, every 3-4 weeks for up to 24 months, over a 30-minute infusion time, but increasing to a 45-minute infusion time if they experienced a clinically relevant rise in serum creatinine that resolved in less than 12-weeks.
- id
- OG001
- title
- 30 - Minute Infusion
- param Type
- NUMBER
- population Description
- Safety Population; enrolled patients who received at least one dose of study medication.
- reporting Status
- POSTED
- time Frame
- 24 Months
- title
- The Number of Participants With Disease Progression
- type
- PRIMARY
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice